Skip to main content

Table 2 Target-to-background ratio of the SUVs and SULs of metastatic lesions in baseline 18F-FDG-PET and 18F-FLT-PET

From: Prospective comparison of early interim 18F-FDG-PET with 18F-FLT-PET for predicting treatment response and survival in metastatic breast cancer

Metastatic site Units Bone Lung Liver Other
18F-FDG-PET SUVs 5.94 ± 4.35 10.81 ± 15.32 3.77 ± 2.57 17.39 ± 21.05
SULs 6.01 ± 4.40 9.22 ± 10.44 2.76 ± 1.85 11.91 ± 9.43
18F-FLT-PET SUVs 1.90 ± 1.91 5.81 ± 4.09 1.00 ± 0.42 10.38 ± 8.23
SULs 2.70 ± 2.67 4.96 ± 2.68 1.04 ± 0.27 7.40 ± 5.56